156 related articles for article (PubMed ID: 18068108)
1. Roxithromycin inhibits the effector phase of delayed-type hypersensitivity.
Liu K; Xu Q
Int Immunopharmacol; 2008 Jan; 8(1):126-31. PubMed ID: 18068108
[TBL] [Abstract][Full Text] [Related]
2. IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed-type hypersensitivity.
Li L; Elliott JF; Mosmann TR
J Immunol; 1994 Nov; 153(9):3967-78. PubMed ID: 7930605
[TBL] [Abstract][Full Text] [Related]
3. Isotype-like suppression of T cell-mediated immunity in vivo. I. Delayed-type hypersensitivity specificity of T cell suppression induced by antigen-binding T cell factors that initiate contact sensitivity.
Ptak W; Bereta M; Ptak M; Askenase PW
J Immunol; 1986 Mar; 136(5):1554-63. PubMed ID: 2419404
[TBL] [Abstract][Full Text] [Related]
4. Astilbin suppresses delayed-type hypersensitivity by inhibiting lymphocyte migration.
Cai Y; Chen T; Xu Q
J Pharm Pharmacol; 2003 May; 55(5):691-6. PubMed ID: 12831513
[TBL] [Abstract][Full Text] [Related]
5. Impaired contact hypersensitivity in diet-induced obese mice.
Katagiri K; Arakawa S; Kurahashi R; Hatano Y
J Dermatol Sci; 2007 May; 46(2):117-26. PubMed ID: 17350227
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of delayed-type hypersensitivity to sheep red blood cells in mice by granulocyte colony-stimulating factor administration at the elicitation phase.
Terashita M; Kudo C; Yamashita T; Gresser I; Sendo F
J Immunol; 1996 Jun; 156(12):4638-43. PubMed ID: 8648107
[TBL] [Abstract][Full Text] [Related]
7. 7'-(3',4'-dihydroxyphenyl)-N-[(4-methoxyphenyl)ethyl]propenamide (Z23), an effective compound from the Chinese herb medicine Fissistigma oldhamii (Hemsl.) Merr, suppresses T cell-mediated immunity in vitro and in vivo.
Hu XD; Zhong XG; Zhang XH; Zhang YN; Zheng ZP; Zhou Y; Tang W; Yang Y; Yang YF; Hu LH; Zuo JP
Life Sci; 2007 Dec; 81(25-26):1677-84. PubMed ID: 18022200
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 6 inhibits delayed-type hypersensitivity and the development of adjuvant arthritis.
Mihara M; Ikuta M; Koishihara Y; Ohsugi Y
Eur J Immunol; 1991 Oct; 21(10):2327-31. PubMed ID: 1915548
[TBL] [Abstract][Full Text] [Related]
9. Regulation of delayed-type hypersensitivity IV. Antigen-specific suppressor cells for delayed-type hypersensitivity induced by lipopolysaccharide and sheep erythrocytes in mice.
Gill HK; Liew FY
Eur J Immunol; 1979 Feb; 9(2):101-6. PubMed ID: 312202
[TBL] [Abstract][Full Text] [Related]
10. Regulation of delayed-type hypersensitivity. I. T suppressor cells for delayed-type hypersensitivity to sheep erythrocytes in mice.
Liew FY
Eur J Immunol; 1977 Oct; 7(10):714-8. PubMed ID: 303999
[TBL] [Abstract][Full Text] [Related]
11. Diversion of CD4+ T cell development from regulatory T helper to effector T helper cells alters the contact hypersensitivity response.
DiIulio NA; Xu H; Fairchild RL
Eur J Immunol; 1996 Nov; 26(11):2606-12. PubMed ID: 8921946
[TBL] [Abstract][Full Text] [Related]
12. Immunotropic activity of vratizolin (ITCL, Denotivir).
MachoĊ Z; Wieczorek Z; Zimecki M
Pol J Pharmacol; 2001; 53(4):377-83. PubMed ID: 11990084
[TBL] [Abstract][Full Text] [Related]
13. Delayed-type hypersensitivity initiation by early-acting cells that are antigen mismatched or MHC incompatible with late-acting, delayed-type hypersensitivity effector T cells.
Ptak W; Herzog WR; Askenase PW
J Immunol; 1991 Jan; 146(2):469-75. PubMed ID: 1987274
[TBL] [Abstract][Full Text] [Related]
14. IL-13 from Th2-type cells suppresses induction of antigen-specific Th1 immunity in a T-cell lymphoma.
Deepak P; Kumar S; Kishore D; Acharya A
Int Immunol; 2010 Jan; 22(1):53-63. PubMed ID: 19951958
[TBL] [Abstract][Full Text] [Related]
15. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses.
Miller SD; Butler LD
J Immunol; 1983 Jul; 131(1):77-85. PubMed ID: 6190929
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of epinastine on the type II-IV allergic reactions in mice, rats and guinea pigs.
Kamei C; Izushi K; Adachi Y; Shimazawa M; Tasaka K
Arzneimittelforschung; 1991 Nov; 41(11):1150-3. PubMed ID: 1687348
[TBL] [Abstract][Full Text] [Related]
17. Signal transducer and activator of transcription 6 is essential in the induction of contact hypersensitivity.
Yokozeki H; Ghoreishi M; Takagawa S; Takayama K; Satoh T; Katayama I; Takeda K; Akira S; Nishioka K
J Exp Med; 2000 Mar; 191(6):995-1004. PubMed ID: 10727461
[TBL] [Abstract][Full Text] [Related]
18. Distribution of cells mediating delayed type hypersensitivity responses of mice to sheep red blood cells.
van der Kwast TH; Benner R
Ann Immunol (Paris); 1977; 128C(4-5):833-40. PubMed ID: 900895
[TBL] [Abstract][Full Text] [Related]
19. Modulation of in vivo immune response by selective depletion of neutrophils using a monoclonal antibody, RP-3. I. Inhibition by RP-3 treatment of the priming and effector phases of delayed type hypersensitivity to sheep red blood cells in rats.
Kudo C; Yamashita T; Araki A; Terashita M; Watanabe T; Atsumi M; Tamura M; Sendo F
J Immunol; 1993 May; 150(9):3728-38. PubMed ID: 8473729
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological profile of a novel phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on acute and chronic inflammation models.
Yamamoto S; Sugahara S; Ikeda K; Shimizu Y
Eur J Pharmacol; 2006 Nov; 550(1-3):166-72. PubMed ID: 17010967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
